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A short isoform of ATG7 fails to 
lipidate LC3/GABARAP
M. H. Ogmundsdottir1, V. Fock1, L. Sooman1, V. Pogenberg2, R. Dilshat1, C. Bindesbøll3, 
H. M. Ogmundsdottir4, A. Simonsen3, M. Wilmanns2 & E. Steingrimsson1
Autophagy is a degradation pathway important for cellular homeostasis. The E1-like enzyme ATG7 is a 
key component of the autophagy machinery, with the main function of mediating the lipidation of LC3/
GABARAP during autophagosome formation. By analysing mRNA-sequencing data we found that in 
addition to the full-length ATG7 isoform, various tissues express a shorter isoform lacking an exon of 27 
amino acids in the C-terminal part of the protein, termed ATG7(2). We further show that ATG7(2) does 
not bind LC3B and fails to mediate the lipidation of members of the LC3/GABARAP family. We have thus 
identified an isoform of ATG7 that is unable to carry out the best characterized function of the protein 
during the autophagic response. This short isoform will have to be taken into consideration when 
further studying the role of ATG7.
Autophagy is a highly conserved clearance pathway of cytoplasmic constituents and is essential for sustaining 
cellular homeostasis1. During this catabolic process, cellular components such as protein aggregates, lipids or 
damaged organelles are delivered to lysosomes, where they become degraded and recycled into building blocks 
for new cellular constituents and for ATP production2. The autophagic response is elicited by various stress 
conditions, ranging from nutrient deprivation to microbial invasion. Several types of autophagy have been 
described, namely macroautophagy, microautophagy and chaperone-mediated autophagy, the latter being less 
well characterized1,2.
Macroautophagy, hereafter referred to as autophagy, starts with the formation of a phagophore, which after 
elongation and cargo sequestration generates a double-membraned autophagosome. The outer autophagosomal 
membrane ultimately fuses with a lysosome, and the enclosed cargo material is broken down by lysosomal hydro-
lases3. In yeast, autophagosome formation is dependent on Atg8, which becomes activated through its covalent 
conjugation to phosphatidylethanolamine (PE). In higher eukaryotes, Atg8 has evolved into the LC3/GABARAP 
family, consisting of LC3A, LC3B, LC3C, GABARAP, GABARAPL1 and GABARAPL2/GATE-163. The function 
of LC3B has been most studied but it is becoming clear that even though sharing sequence similarity, the LC3/
GABARAP proteins play different roles in both autophagy activity and autophagy-independent processes4.
Autophagy-related genes (ATGs) and their associated enzymes form the core molecular machinery of auto-
phagosome formation, which was initially described in yeast5 and has subsequently been shown to be conserved 
in other species including humans6. A case in point is ATG7, an E1-like enzyme, which forms a central element of 
two ubiquitin-like conjugation systems required for the lipidation of LC3/GABARAP3. In the first system, ATG7 
binds and transfers ATG12 to the E2-like enzyme ATG10, which then transfers ATG12 to ATG5. ATG12-ATG5 
in complex with ATG16L1 acts as an E3-like enzyme in the final step of LC3/GABARAP-PE conjugation. In the 
other conjugation system, the C-terminal domain of ATG7 binds LC3/GABARAP prior to the formation of a 
thioester bond. LC3/GABARAP is subsequently transferred to the E2-like enzyme ATG3 before being conju-
gated to PE, a process mediated by ATG12-5/ATG16L13. In the growing phagophore, LC3/GABARAP recruits 
autophagy cargo binding proteins, such as p62 (SQSTM1), which are degraded along with the cargo upon fusion 
of autophagosomes with lysosomes. In this study, we have identified an isoform of ATG7 that fails to mediate the 
lipidation of LC3/GABARAP.
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Results
Two isoforms of ATG7 are expressed in various tissues. According to the Ensembl and RefSeq data-
bases, three protein coding splice variants of human ATG7 exist. Compared to the longest isoform ATG7(1), 
isoform 2 lacks an exon of 27 amino acids near the C-terminus of the protein, whereas isoform 3 lacks 39 and 
41 amino acids from the N- and C- termini, respectively (Fig. 1A, Supplementary Fig. 1A). We analysed the 
expression of ATG7 isoforms utilizing RNA-sequencing data from the Genotype-Tissue Expression (GTEx) and 
The Cancer Genome Atlas (TCGA) databases (Fig. 1B). This revealed high expression of ATG7(1), moderate 
expression of ATG7(2) and low expression of ATG7(3) in the various tissues. Furthermore, we analysed pub-
lished RNA-sequencing data from human embryonic kidney (HEK293) cells7, human hepatocellular carcinoma 
(HepG2) cells7 as well as RNA-sequencing data from normal and tumour samples obtained from human livers8. 
This showed a similar expression pattern, with the highest expression of ATG7(1), lower expression of ATG7(2) 








































Figure 1. ATG7 isoforms show differential expression pattern. (A) Schematic representation of ATG7 isoforms. 
Location of exons lacking in isoforms 2 and 3 is indicated. (B) RNA-seq data from various tissues obtained 
from GTEX (left panel) and TCGA (right panel) databases were analysed for the expression of ATG7; sample 
names are indicated on the left, from top to bottom: GTEX: bone marrow, cervix uteri, bladder, fallopian tube, 
kidney, liver, blood, pituitary, nerve, testis, prostate, small intestine, colon, stomach, oesophagus, pancreas, 
spleen, lung, thyroid, adrenal gland, brain, salivary gland, skin, breast, vagina, uterus, ovary, heart, blood 
vessel, muscle, adipose tissue. TCGA: uveal melanoma (UVM), uterine carcinosarcoma (UCS), uterine corpus 
endometrial carcinoma (UCEC), thymoma (THYM), thyroid carcinoma (THCA), testicular germ cell tumour 
(TGCT), stomach adenocarcinoma (STAD), skin cutaneous melanoma (SKCM), sarcoma (SARC), rectum 
adenocarcinoma (READ), prostate adenocarcinoma (PRAD), pheochromocytoma and paraganglioma (PCPG), 
pancreatic adenocarcinoma (PAAD), ovarian serous cyst adenocarcinoma (OV), mesothelioma (MESO), lung 
squamous cell carcinoma (LUSC), lung adenocarcinoma (LUAD), liver hepatocellular carcinoma (LIHC), brain 
lower grade glioma (LGG), acute myeloid leukaemia (AML), kidney renal papillary cell carcinoma (KIRP), 
kidney clear cell carcinoma (KIRC), head and neck squamous cell carcinoma (HNSC), glioblastoma multiforme 
(GBM), oesophageal carcinoma (ESCA), diffuse large B-cell lymphoma (DLBC), colon adenocarcinoma 
(COAD), cholangiocarcinoma (CHOL), cervical and endocervical cancer (CESC), breast invasive cancer 
(BRCA), bladder urothelial carcinoma (BLCA), adrenocortical cancer (ACC).
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obtained from HEK293T cells and the human hepatocellular carcinoma cell lines HepG2 and HuH7, confirming 
the expression of both isoforms in these cells (Supplementary Fig. 1C).
ATG7(2) does not bind LC3B. Alignment of the amino acid sequence lacking in ATG7(2) showed that it is 
present in species ranging from yeast to human (Fig. 2A). The crystal structure of yeast Atg7 has been resolved in 
the apo form and in a complex with other Atg proteins, namely Atg3, Atg8 and Atg109–13. The human and yeast 
ATG7 proteins are highly conserved, sharing approximately 45% sequence identity despite the distant genetic 
relation between the two species (Supplementary Fig. 2). We thus made use of the yeast Atg7 crystal structure for 
characterizing a potential role of the exon missing in isoform 2. ATG7 homodimerizes via its C-terminal domain 
where residues I626-F633 form part of the dimerization interface (Fig. 2B). These amino acids are absent in 
ATG7(2), suggesting that the homodimerization ability of this short isoform is compromised. In addition, the 27 
amino acids that are absent in ATG7(2) (I626-K652) are partially involved in key secondary structure elements, 
which may affect the overall folding of the domain in which they are encompassed. We therefore hypothesized 
that the solubility of ATG7(2) might be different from that of ATG7(1). To test this, HEK293T cells were trans-
fected with ATG7(1) or ATG7(2) and protein lysates were prepared using differential detergent extraction14. 
Western blotting revealed that both isoforms were present in the soluble fraction, whereas an increased por-
tion of ATG7(2) was present in the insoluble fraction when compared with ATG7(1) (Fig. 2C, Supplementary 
Fig. 3A). In yeast, residues R550, F552, H554, L559, L561, T563, P564 and Y566 (which correspond to R627, 
F629, S631, V636, P638, S640, L641 and F643 in human ATG7) are exposed at the surface and interact directly 
with Atg8 in the crystal structure of the Atg7/Atg8 complex. These residues are lacking in ATG7(2) and thus the 
protein would be expected to exhibit decreased binding with the human Atg8 orthologues; LC3/GABARAPs. We 
tested this by co-transfecting HEK293T cells with FLAG-tagged LC3B and Myc-tagged ATG7(1) or ATG7(2), 
followed by immunoprecipitation of 3xFLAG-LC3B. Indeed, Western blot analysis revealed that LC3B interacts 






































































Figure 2. ATG7 isoform 2 is not able to bind LC3. (A) Amino acid sequence alignment of ATG7 from S. 
cerevisae, D. melanogaster, C. elegans, H. sapiens and M. musculus. The exon lacking in human ATG7(2) is 
underlined (I626-K652). (B) Representation of the yeast Atg7 dimer showing the protomer surfaces colored in 
faint green or gray. Other ATG proteins, in ribbon representation, are shown to indicate their location in the 
respective protein complexes. The region lacking in human isoform 2 is shown in dark blue. (C) HEK293T cells 
were transfected with the two isoforms of Myc-tagged ATG7 or empty vector (EV) and protein lysates were 
prepared using differential detergent extraction prior to Western blot analysis. Membranes were probed with 
ATG7 and Actin antibodies. Quantification of band intensities was performed using ImageJ software. Error 
bars represent SEM of four independent experiments. Two-way Anova with Sidak’s multiple comparisons test 
was performed revealing no significant statistical difference. (D) Co-immunoprecipitation experiments in 
HEK293T overexpressing Myc-tagged empty vector (EV), ATG7(1) or ATG7(2), together with 3xFLAG-LC3. 
Constructs were detected using ATG7 and FLAG antibodies, respectively.
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ATG7(2) is unable to lipidate LC3/GABARAP. Given the lost interaction of ATG7(2) with LC3B, we 
predicted that this isoform would fail to lipidate LC3. To test this, we used Atg7 knockout mouse embryonic 
fibroblasts (Atg7−/− MEFs) to generate stable cell lines expressing FLAG-tagged human ATG7(1) or ATG7(2). 
Immunostainings revealed similar expression levels of ATG7(1) and ATG7(2) and both isoforms showed a pre-
dominantly cytoplasmic staining pattern (Fig. 3A). We also assessed the expression of endogenous LC3B in the 
respective cell lines. Lipidated LC3B, which is present at the autophagosomal membrane, is often observed as 
puncta within the cytoplasm, whereas unlipidated LC3B shows a more diffuse staining15. Surprisingly, confocal 
imaging revealed a similar number of LC3B-positive puncta in both wild type (wt) and Atg7−/− MEFs express-











































































































































































Figure 3. ATG7 isoform 2 fails to lipidate LC3/GABARAP. (A) Wild type MEFs or Atg7−/− MEFs stably 
expressing FLAG-tagged empty vector (EV), ATG7(1) or ATG7(2) were treated with Bafilomycin-A1 (Baf-A1) 
or vehicle control (DMSO) for 4 h and stained with FLAG (red) and LC3B (green) antibodies. Representative 
images of three experiments are shown. Scale bar represents 20 µm and applies to all images. (B) Quantification 
of LC3B puncta was performed using CellProfiler software. Error bars represent SEM of three independent 
experiments. Two-way Anova with Sidak’s multiple comparisons test was performed revealing no significant 
statistical difference. (C) Long-lived protein degradation (LLPD) assay of wild type MEFs or Atg7−/− MEFs 
stably expressing FLAG-tagged empty vector (EV), ATG7(1) or ATG7(2), treated with Baf-A1 or DMSO 
for 4 h. Error bars represent SEM of three independent experiments. Two-way Anova with Sidak’s multiple 
comparisons test was performed revealing no significant statistical difference. (D) Western blot analysis of 
lysates from wild type MEFs or Atg7−/− MEFs stably expressing FLAG-tagged empty vector (EV), ATG7(1) or 
ATG7(2), treated with Baf-A1 or DMSO for 4 h. Membranes were probed with antibodies against FLAG, p62, 
LC3A, LC3B and Actin. (E) Quantification of band intensities was performed using ImageJ software. Error bars 
represent SEM of three independent experiments. Two-way Anova with Sidak’s multiple comparisons test was 
performed to determine statistical significance of ATG7(1) or ATG7(2) expressing Atg7−/− MEFs compared to 
EV Atg7−/− MEFs. *p < 0.05.
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the ATG7(1) and ATG7(2) overexpression cell lines. Treatment with the autophagy degradation inhibitor 
Bafilomycin-A1 (Baf-A1) did not lead to significant changes in the number of LC3B puncta in any of the cell 
lines when compared to the vehicle control (Fig. 3A,B). Likewise, all cell lines exhibited similar numbers of LC3B 
puncta under starvation conditions (Supplementary Fig. 4A,B). We also monitored autophagy flux in the pres-
ence or absence of Baf-A1 by means of long-lived protein degradation (LLPD) assays. Our data revealed that both 
wt and Atg7−/− MEFs expressing an EV showed comparable levels of protein degradation under basal conditions, 
which were slightly decreased in the presence of Baf-A1 (Fig. 3C). Overexpression of ATG7(1) or ATG7(2) was 
not sufficient to further enhance the degradation of long-lived proteins in Atg7−/− MEFs.
To assess the lipidation activity of the two ATG7 isoforms, we performed Western blot analyses for members 
of the LC3/GABARAP family. Of note, the LC3/GABARAP proteins migrate faster in SDS-PAGE gels when 
lipidated, resulting in two bands with an upper unlipidated (LC3-I) and lower lipidated (LC3-II) protein15. As 
expected, wt MEFs showed two bands each for LC3A (LC3A-I and LC3A-II) and LC3B (LC3B-I and LC3B-II), 
indicative of functional lipidation (Fig. 3D, Supplementary Fig. 3C). Treatment of these cells with Baf-A1 resulted 
in an accumulation of the lipidated lower bands of LC3A and LC3B, whereas no lipidation was observed in 
Atg7−/− MEFs, confirming that Atg7 is crucial for the lipidation event. Overexpression of ATG7(1) rescued the 
lipidation of LC3A and LC3B in Atg7−/− MEF cells, whereas the shorter ATG7(2) isoform clearly failed to lipidate 
the two proteins. A similar pattern was observed for GABARAP (Supplementary Fig. 4C), however, due to low 
expression and unspecific bands of GABARAP-II, we did not quantify the lipidation of this protein. Finally, we 
analysed the expression levels of the autophagy cargo receptor p62 in the different cell lines. The Atg7−/− MEFs 
showed increased levels of p62 when compared to the parental cells (Fig. 3D,E, Supplementary Fig. 3C), in line 
with the inability of the knockout cells to form lipidated LC3. Consistent with that, ATG7(1) expression signifi-
cantly reduced the levels of p62, whereas ATG7(2) failed to alter p62 expression.
Discussion
We have identified an isoform of ATG7 that is unable to carry out the best characterized function of the protein, 
namely the lipidation of LC3/GABARAP. For performing its activity, ATG7 directly interacts with and activates 
LC3/GABARAP16. Sequence alignment and structural analyses revealed that both full-length ATG7(1) and the 
shorter ATG7(2) isoform contain a critical cysteine residue (C572), which is involved in a thioester bond for-
mation with ATG8 and ATG12, whereas a region important for the initial binding of ATG7 to ATG8 is lost in 
the short ATG7(2) isoform. Indeed, we did not detect any interactions between ATG7(2) and LC3B. This loss 
of binding is presumably the reason why ATG7(2) is unable to lipidate LC3/GABARAP. It is also possible that 
ATG7(2) can bind to other proteins through its C-terminal domain, however, the binding interface has not yet 
been characterized.
Knockout of either Atg5 or Atg7 in mice leads to neonatal death17,18, thus highlighting the importance of 
these genes. Knockdown and overexpression studies of ATG5 or ATG7 have revealed various effects on the phe-
notypes of different cell types, usually ascribed to altered autophagy function. However, an autophagy pathway 
independent of Atg5 and Atg7 also exists19. Mouse embryonic fibroblasts devoid of Atg5 or Atg7 are still able to 
form autophagosomes without lipidated LC3 and carry out some autophagy degradation. Accordingly, wt MEFs 
and Atg7−/− MEFs did not show a difference in the degradation of long-lived proteins at basal conditions. In 
addition, we did not detect changes in the number of endogenous LC3B puncta when comparing parental and 
Atg7−/− MEFs, or cells overexpressing the two different ATG7 isoforms. However, immunoblotting revealed a 
clear difference between the four cell lines, with lipidated LC3A and LC3B proteins only appearing in the presence 
of the full-length ATG7(1) isoform. Together, these findings highlight that caution has to be taken when linking 
LC3 puncta to the amount of lipidated LC3 or to the number of autophagosomes20.
The physiological function of the short ATG7(2) isoform remains unknown and it may serve a role that is 
unrelated to autophagy. Interestingly, ATG7 has previously been shown to exert functions independent of its 
lipidation activity, including regulation of the cell cycle and apoptosis through binding of TP5321. ATG7(2) 
might also act as a dominant negative regulator of the full-length ATG7(1) isoform in order to further modulate 
autophagy activity. Our analysis of GTEx mRNA expression data showed that ATG7(2) is highly expressed in 
blood, which could suggest a role in the hematopoietic system. It is important to note, however, that expres-
sion of the different protein isoforms remains to be mapped in both healthy and diseased tissues. Finally, it also 
requires further investigation how the expression of the different ATG7 isoforms is regulated. In this context it 
has been shown that abnormal splicing, which leads to a longer ATG7 transcript, decreases ATG7 protein levels22. 
Importantly, it has to be taken into account that knockdown of ATG7 mRNA will influence the levels of both 
ATG7(1) and ATG7(2), which can vary between cell types. Further characterizing this shorter ATG7(2) isoform 
will be important for future autophagy research, both regarding the role of autophagy in healthy cells but also in 
diseased states.
Materials and Methods
Analysis of RNA-seq data. The heatmap for ATG7(1) (ENST00000354449), ATG7(2) (ENST00000354956) 
and ATG7(3) (ENST00000446450) was generated using Xena Browser23. RNA-seq data were selected from Xena 
data hubs including GTEx (Genotype-Tissue Expression) and TCGA (The Cancer Genome Atlas) data. The sam-
ples were sorted based on study type and then by primary sites. For each sample, log2 of the expected count value 
from RNA-seq data was used for plotting. The results shown here are in part based upon data generated by the 
TCGA Research Network: http://cancergenome.nih.gov/. The GTEx Project was supported by the Common Fund 
of the Office of the Director of the National Institutes of Health, and by NCI, NHGRI, NHLBI, NIDA, NIMH, and 
NINDS. The data used for the analyses described in this manuscript were obtained utilizing the Xena Browser 
on 08/31/2018.
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Structural analysis of ATG7. The yeast ATG7 apo structure (PDB 3VH2)9 was superimposed with yeast 
complex structures ATG7-ATG8 (PDB 3VH3)9, ATG7-ATG3 (PDB 4GSL)10 and ATG7-ATG10 (PDB 4GSL)10 
in Pymol (The PyMOL Molecular Graphics System, Schrödinger, LLC.). Graphics and representation were pur-
sued in Pymol. The following ATG7 protein sequences were obtained from UniProt (http://www.uniprot.org/): 
Saccharomyces cerevisiae P38862, Caenorhabditis elegans G5EBK4, Drosophila melanogaster Q7JY94, Mus mus-
culus Q9D906, Homo sapiens isoform 1 O95352, Homo sapiens isoform 2 O95352-2, Homo sapiens isoform 3 
O95352-3. Sequences were aligned using Clustal Omega24,25 and BoxShade (http://embnet.vital-it.ch/software/
BOX_form.html) was used for converting the alignment file to a PICT file.
Cell culture and transient transfections. Embryonic fibroblasts from Atg7 knockout mice (Atg7−/− 
MEFs) were kindly provided by Dr. Masaaki Komatsu and cultured as described previously18. HEK293T cells 
were maintained in DMEM supplemented with 10% FBS. All cell lines were kept at 37 °C in 5% CO2 and sub-
cultured to 80% confluency. Transient transfections were performed using FuGENE HD reagent (Promega, 
Madison, WI) according to the manufacturer’s instructions. The Atg7−/− MEF overexpression cell lines were 
generated by co-transfecting cells with a TRE plasmid containing FLAG-tagged ATG7(1), ATG7(2) or an empty 
vector (EV), together with plasmids containing the piggybac transposase and reverse tetracycline transactivator 
rtTA with Neomycin selection. Cells were grown in selection medium with G418 (0.5 µg/µl), which was added to 
the medium 2 days after transfection. Expression of the constructs was induced by adding 0.1 µg/ml (isoform 1) 
or 1 µg/ml (EV and isoform 2) doxycycline to the cells for 24 h prior to lysis or fixation.
Expression constructs. The CMV-ATG7-Myc construct expressing isoform 2 of ATG7 was kindly pro-
vided by Dr. Toren Finkel (NIH, Bethesda) and obtained through Addgene (#24921)26. The full-length ATG7(1) 
was generated using the CMV-ATG7(2)-Myc as a template and the Q5 Site-directed Mutagenesis Kit (New 
England Biolabs, Ipswich, MA) with the following primers: A TG 7( 1) -F, C AG CCTGGCATTTGACAAATGTA 
CAGCTTGTTCTTCCAAAGTTCTTGATCAATATGAACGAGAAGGATTTAAC and ATG7(1)-R, ACGGG 
AAGGACATTATCAAACCGTGAAAGAAATCCCCGGATCTGGTGAGGCACAAGCCC. ATG7 was excised 
from CMV-ATG7-Myc using EcoRI and NotI and cloned into a piggybac vector downstream of a tetracycline 
response element (TRE). The piggybac constructs were a kind gift from Dr. Kazuhiro Murakami (Hokkaido 
University)27. Constructs were verified by Sanger sequencing. 3xFLAG-LC3B was made using Gateway LR-cloning 
of p-ENTR-LC3B into pDEST-3xFLAG and generously provided by Trond Lamark (University of Tromso).
Antibodies. The following antibodies were used for immunofluorescence (IF) and Western blotting (WB): 
mouse anti-Actin (clone C4, Millipore MAB1501R, WB: 1:10000), rabbit anti-Actin-β (clone 13E5, Cell Signaling 
Technology 4970, WB: 1:4000), rabbit anti-ATG7 (clone EP1759Y, Millipore 04-1055, WB: 1:10000), mouse 
anti-FLAG (clone M2, Sigma-Aldrich F3165, IF: 1:5000, WB: 1:5000), rabbit anti-LC3A (clone D50G8, Cell 
Signaling Technology D50G8, WB: 1:1000), rabbit anti-LC3B (clone D11, Cell Signaling Technology 2775, IF: 
1:250, WB: 1:1000), rabbit anti-GABARAP (clone E1J4E, Cell Signaling Technology 13733, WB: 1:1000) and 
guinea pig anti-p62/SQSTM1 (Progen Biotechnik GmbH GP62-C, WB: 1:1000).
Immunofluorescence staining and confocal microscopy. Cells were seeded onto 8-well glass slides 
at a density of 1.5 × 104 cells/well and incubated overnight in the presence of 0.1 µg/ml (isoform 1) or 1 µg/ml 
(EV and isoform 2) doxycycline. 24 h post-induction, the culture medium was replaced and cells were treated 
with either 100 nM Bafilomycin (Santa Cruz Biotechnology) or vehicle control (DMSO) for 4 h. Subsequently, 
cells were fixed with 4% formaldehyde (Thermo Scientific) and incubated with blocking buffer (5% normal 
goat serum/0.3% Triton X-100 in PBS) for 1 h at room temperature. Following staining with primary antibodies 
diluted in PBS containing 1% BSA and 0.3% Triton X-100 overnight at 4 °C, cells were incubated with Alexa 
Fluor 546 or 555 anti-mouse or anti-rabbit IgG secondary antibodies (Life Technologies) for 1 h at room tem-
perature and counterstained with DAPI (Invitrogen, Carlsbad, CA). Finally, slides were mounted in Fluoroshield 
(Sigma-Aldrich) and images were acquired on a confocal microscope (Olympus FLV1200). Representative images 
of at least three independent experiments are shown. LC3B puncta were quantified using CellProfiler software 
and the number of puncta was normalized to the number of nuclei.
Western blotting. Cells were seeded onto 24-well plates at a density of 5 × 104 cells/well and incubated over-
night in the presence of 0.1 µg/ml (isoform 1) or 1 µg/ml (EV and isoform 2) doxycycline. 24 h post-induction, the 
culture medium was replaced and cells were treated with either 100 nM Bafilomycin (Santa Cruz Biotechnology) 
or vehicle control (DMSO) for 4 h. Proteins were extracted through whole cell lysis in sodium dodecyl sulphate 
(SDS) sample buffer (2% SDS, 5% 2-Mercaptoethanol, 10% glycerol, 63 mM Tris-HCl, 0.0025% Bromophenol 
blue, pH 6.8) and boiling for 5 min at 95 °C. Protein lysates (10–20 µg) were loaded onto 8% or 12.5% gels, sep-
arated by SDS polyacrylamide gel electrophoresis (PAGE) and blotted onto methanol-activated polyvinylidene 
difluoride (PVDF) membranes (Thermo Scientific). After blocking with 5% BSA (Sigma-Aldrich, St. Louis, MO) 
in Tris-buffered saline containing 0.1% Tween-20, membranes were probed with primary antibodies overnight at 
4 °C. DyLight 800 anti-mouse, DyLight 680 anti-rabbit (Cell Signaling Technology) or DyLight 800 anti-guinea 
pig (LI-COR Biosciences) IgG secondary antibodies were applied for 1 h at room temperature. The blots were 
scanned with Odyssey imaging system and Image Studio version 2.0 (LI-COR Biosciences). All Western blots 
were repeated in at least three independent experiments and representative blots are shown for each experiment. 
Cropped blots are presented in main figures and whole scans are shown in Supplementary Fig. 3.
FLAG-immunoprecipitation. HEK293T cells were plated onto 5 cm dishes at a density of 1 × 106 cells and 
incubated overnight, before being co-transfected with Myc-tagged EV, ATG7(1) or ATG7(2) and 3xFLAG-tagged 
LC3B constructs. The following day (24 h post-transfection), approximately 2 × 106 HEK293T cells per condition 
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were solubilized in lysis buffer (1% Triton-X, 50 mM Tris-HCl pH 7.4, 150 mM NaCl, 1 mM EDTA) supplemented 
with protease inhibitors (Sigma-Aldrich). The soluble fraction was incubated with ANTI-FLAG M2-Affinity Gel 
(Sigma-Aldrich) on a roller shaker for 2 h at 4 °C. Proteins bound to the beads were eluted using 3X FLAG peptide 
at a final concentration of 150 ng/μl (Sigma-Aldrich). After three washing steps, samples were resuspended in 2X 
SDS sample buffer and subjected to Western blotting.
Aggregation assay. To monitor the formation of protein aggregates, differential detergent extraction was 
carried out as previously described14. Briefly, soluble proteins were first extracted from transiently transfected 
HEK293T cells using a mild lysis buffer (1% Triton X-100, 50 mM NaCl, 10 mM Tris pH 7.5, 5 mM EDTA), fol-
lowed by centrifugation at 16,000 × g for 10 min at 4 °C. The pelleted fraction was then washed with PBS and sol-
ubilized using a harsher lysis buffer (2% SDS, 50 mM Tris pH 7.5, 1 mM EDTA) and sonication (medium power, 
30 sec on/30 sec off) for 5 min using a Bioruptor ultrasonicator (Diagenode). Finally, samples were resuspended 
in 2X SDS sample buffer and subjected to Western blotting.
Long-lived protein degradation assay. Cells were grown in 24-well plates for 48 h in RPMI and 10% 
FBS supplemented with 10 mM 14C-L-Valine and appropriate concentrations of doxycycline. Subsequently, cells 
were washed with PBS and grown in RPMI and 10% FBS supplemented with 10 mM L-Valine for 16 hours. The 
medium was then changed to a) RPMI, 10 mM Valine and vehicle control (DMSO), b) RPMI, 10 mM Valine and 
100 nM Baf-A1, c) HBSS (#14025-050, Gibco), 10 mM Valine and vehicle control (DMSO) or d) HBSS, 10 mM 
Valine and 100 nM Baf-A1. After 4 hours, the supernatant was collected, 50% TCA added and proteins precipi-
tated overnight at 4 °C. The cells were lysed with 0.2 M KOH overnight at 4 °C. Supernatants were centrifuged and 
moved into a new tube, the precipitate dissolved and moved to the same sample cell lysate. Both supernatant and 
lysate were transferred to counting vials and mixed with 3 mL scintillation fluid (Ultima Gold #6013321, Perkin 
Elmer). 14C levels were measured in each sample using a Packard Liquid Scintillation Analyser. The percentage 
of degradation was determined by comparing the amount of 14C in the supernatant to the total 14C levels (super-
natant and lysate).
Statistics. All data are expressed as mean ± SEM. Statistical analyses were conducted using GraphPad Prism 
6 (GraphPad Software). Analysis of more than two groups was performed using a two-way ANOVA followed by 
Sidak’s multiple comparisons test. P-values lower than 0.05 were considered statistically significant.
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